Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG-750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG-745).
Byungwook KimKi Young HuhKyung-Sang YuSeung Hwan LeePublished in: British journal of clinical pharmacology (2024)
The oral formulation of ivaltinostat (CG-750) was generally well tolerated after a single dose. CG-750 displayed a mean bioavailability of 10.6%.
Keyphrases